Fort Myers-based NeoGenomics expects big revenue increase for 2025

Fort Myers-based cancer testing and research lab NeoGenomics expects to report double-digit revenue growth for 2025. However, ...

NeoGenomics Appoints Abhishek Jain to CFO Role

NeoGenomics appointed Abhishek Jain to the role of chief financial officer, succeeding Jeff Sherman, who is set to retire from the position in March.
PharmiWeb

NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue

Anticipates preliminary unaudited fourth quarter 2025 revenue of approximately $190 million; full-year 2025 revenue of $727 ...

NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. "Jack" Kenny to its Board of Directors

(NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the ...
Nasdaq

NeoGenomics Announces Grand Opening of New Pharma Services Laboratory in Singapore

Lab is located in same building as PPD® Laboratories’ Central Lab and will support Asia-Pacific oncology trials Fully integrated with PPD’s CRO capabilities, PPD Laboratories offers bioanalytical, ...
Business Wire

PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions

WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO), and NeoGenomics Laboratories, Inc., a leading provider of ...
Nasdaq

NeoGenomics Announces Plans to Expand Global Footprint in Pharma Services by Opening Clinical Research Laboratory in Suzhou, China

FORT MYERS, FL / ACCESSWIRE / October 13, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced plans to open a ...